Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An MMP-9 mutant without gelatinolytic activity as a novel TIMP-1-antagonist.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology - 1 Sept 2000

Roeb E, Behrmann I, Grötzinger J, Breuer B, Matern S

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Sequence
Share to COS Cells
Share to Fibrosis
Share to Gelatinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Matrix Metalloproteinase 9

Share to Tissue Inhibitor of Metalloproteinase-1

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 10973913
DOI: 10.1096/fj.99-0947fje

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An MMP-9 mutant without gelatinolytic activity as a novel TIMP-1-antagonist.PMID 10973913Read ↗

The activity of a designer tissue inhibitor of metalloproteinases (TIMP)-1 against native membrane type 1 matrix metalloproteinase (MT1-MMP) in a cell-based environment.Semantic proximity Read ↗

Chemical Biology for Understanding Matrix Metalloproteinase FunctionSemantic proximity Read ↗

Matrix metalloproteases: Underutilized targets for drug deliverySemantic proximity Read ↗

Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseasesSemantic proximity Read ↗

Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013–2023)Semantic proximity Read ↗

Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.Semantic proximity Read ↗

Matrix Metalloproteinases: New Directions Toward Inhibition in the Fight Against CancersSemantic proximity Read ↗

Effect of TIMPs and Their Minimally Engineered Variants in Blocking Invasion and Migration of Brain Cancer CellsSemantic proximity Read ↗

Discovery of potent and specific inhibitors targeting the active site of MMP-9 from the engineered SPINK2 library.Semantic proximity Read ↗

Potential clinical implications of recent matrix metalloproteinase inhibitor design strategiesSemantic proximity Read ↗

Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition.Semantic proximity Read ↗

The canonical methionine 392 of matrix metalloproteinase 2 (gelatinase A) is not required for catalytic efficiency or structural integrity: probing the role of the methionine-turn in the metzincin metalloprotease superfamily.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.